Skip navigation
Government of South Australia - Department of State Development

    Clinical trials company finding solutions to international healthcare challenges

    Tis bg3

    CMAX Clinical Research has been a leader in delivering early phase clinical trials for more than 30 years, making it one of the most respected clinical trial businesses in Australia.

    CMAX Clinical Research has been a leader in delivering early phase clinical trials for more than 30 years, making it one of the most respected clinical trial businesses in Australia.

    The company’s custom-built facility, opposite the Royal Adelaide Hospital and within Adelaide BioMed City, conducts clinical trials for sponsor companies from all over the world.

    This location provides ready access to state-of-the-art facilities, equipment and world-class medical and pharmacology specialists working at Adelaide BioMed City which co-locates universities, government, hospitals and more than 2,000 researchers.

    The South Australian Government has provided support to CMAX over many years with the Invest SA team and global office network helping to identify potential customers and close a number of deals (particularly in South Korea and China).

    CMAX has also worked with the South Australian Government to build connections at global healthcare events like the BIO International Convention in Boston, which DSD has led a Team Australia delegation to for four years running. The company has also benefited from grant funding for research and commercialisation activities.

    Jane KELLY CEO CMAX

    “Adelaide has been set-up, like no other city in Australia, to be the best place to conduct clinical research. Not only can we offer great speed to start-up for early phase clinical trials, but we have access to all the specialists we need at Adelaide BioMed City.

    “Adelaide’s innovation ecosystem is resulting in world class clinical trial innovation and investment, with customers keen to capitalise on South Australia’s speed, quality and value.”

    Jane Kelly, Chief Executive Officer, CMAX

    Sources:

    Human trials to begin on SA-made universal pneumococcal vaccine

    About clinical trials in SA | SA Health